Advancing Access to HIV/HCV Testing for People Who Inject Drugs (PWID)
Part of paid clinical trials in Miami, Florida.
- Sponsor
- University of Miami
- Study ID
- NCT06730555
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Accepted
Interventions
- ACCESS Intervention — BEHAVIORALParticipants will receive the ACCESS intervention with funding, consisting of up to 16 hours of practice facilitation per month in person and/or virtually. Practice facilitation is training and support on implementation of routine HIV/HCV screening.
- Control Group — BEHAVIORALParticipants will receive a link to the CDC compendium of evidence-based interventions for HIV prevention.
Study Details
The purpose of this study is to test the effectiveness of the ACCESS strategy: an organizational-level intervention that uses funding and practice facilitation to improve the organizational capacity of syringe services programs (SSPs) to implement routine, opt-out HIV and Hepatitis C (HCV) testing and linkage to care for people who inject drugs (PWID).
Key Dates
- Start date
- Jun 27, 2025
- Status verified
- Sep 2025
- Primary completion
- Aug 1, 2028
- Completion
- Aug 1, 2028
Study Design
- Enrollment
- 40 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- SCREENING
Arms
- Experimental: ACCESS GroupParticipants in this group will receive the ACCESS intervention for up to 18 months
- Active Comparator: Control GroupParticipants in this group will receive a link to the CDC Compendium of Evidence-Based Interventions for up to 18 months.
Primary Outcome Measure
Number of SSP participants reached [ Time Frame: up to 18 months ]
Central Contacts
- Hansel Tookes, MD3056897030
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Miami | Miami | Florida | 33136 | Hansel Tookes, MD (PRINCIPAL_INVESTIGATOR) Tyler Bartholomew, PhD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Miami, FL
By condition
By specialty
By research site
Related Studies
- Comparing Mobile Health Strategies to Improve Pre-exposure Prophylaxis Use (PrEP) for HIV PreventionRecruiting · Public Health Foundation Enterprises, Inc. · San Francisco, California
- A Study to Investigate Pharmacokinetics, Safety and Tolerability of Long-Acting Cabotegravir Plus Recombinant Human Hyaluronidase PH20 in Healthy Adult ParticipantsPHASE1 · Recruiting · ViiV Healthcare · Orlando, Florida
- Pharmacokinetics, Safety, Tolerability of Dolutegravir/Rilpivirine in PediatricsPHASE1/PHASE2 · Recruiting · ViiV Healthcare · Long Beach, California
- Comprehensive HIV and Harm Prevention Via TelehealthRecruiting · University of Miami · Miami, Florida